Tag: Prescription Drugs
FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years
Risdiplam Beneficial for Infants With Genetically Diagnosed Spinal Muscular Atrophy
Improved functional, survival outcomes seen with risdiplam treatment before development of clinical signs or symptoms
Dalbavancin Noninferior to Standard Therapy for Complicated S. Aureus Bacteremia
Dalbavancin not superior to standard therapy, but met the noninferiority criterion
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
Treatment linked to reduced rates of first occurrence of suicidal behaviors, substance misuse, transport accidents, criminality
Study IDs Inflammatory Pathways Contributing to Asthma Exacerbations in Children
Children receiving mepolizumab have increased expression of gene modules linked to epithelial and macrophage inflammatory pathways
Ivabradine Aids Symptoms of Postural Orthostatic Tachycardia Syndrome
Patients with POTS treated with ivabradine have better heart-rate control when standing
Revakinagene Taroretcel Reduces Ellipsoid Zone Area in Macular Telangiectasia Type 2
Reduced ellipsoid zone area seen with revakinagene taroretcel compared with sham procedure
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
Lower odds of relapse seen among Medicare beneficiaries in prescription drug plans, Medicare Advantage Prescription Drug plans
Oseltamivir for Flu Tied to Reduced Risk for Serious Neuropsychiatric Events in Children
Event rates were lower during oseltamivir-treated influenza periods and posttreatment periods vs. untreated influenza
